Zydus Cadila arm to sell 2 brands Mifegest, Cytolog to Integrace
Ahmedabad: Zydus Healthcare Limited, a wholly owned subsidiary of Zydus Cadila has announced that the company has entered into an agreement with Integrace Private Limited ("Purchaser") to sell two brands viz. Mifegest and Cytolog.
The companies have entered into an agreement on September 20, 2021.
"The said transaction is expected to be completed within 30 days from the date of execution of agreement subject to customary approvals," the company said in a BSE filing.
Integrace is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
Read also: Zydus Healthcare gets CDSCO panel nod for study of Indacaterol, Budesonide inhaler
Headquartered in Ahmedabad, the company discovers, develops, manufactures, and markets a broad range of healthcare therapies.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.